Celgene Corporation (CELG) - Earnings & Price History

CELG: Celgene Corporation - 117.54, $91.04B, 1.83 (1.58%)

Sector: Healthcare - Industry: Biotechnology

Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID to treat multiple myeloma; and OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis, psoriasis, ankylosing spondylitis, Beh├žet's disease, atopic dermatitis, and ulcerative colitis. The companys products also include VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML); THALOMID for the patients with multiple myeloma and erythema nodosum leprosum; ISTODAX to treat cutaneous

Past CELG reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-01-26BMO1.59111.53113.98114.58111.061150.53%-2.66%-2.15%2.03M
2016-10-27BMO1.48104.7298.41101.81101.67106.133.45%2.86%6.41%11.04M
2016-07-28BMO1.39111.26108.11109.91109.8112.251.66%1.23%2.91%8.32M
2016-04-28BMO1.28108.03106.15107.73103.36110.21.49%▲0.28%1.77%8.53M
2016-01-28BMO1.2297.21102.31101.595.1102.35-0.79%-4.23%-4.98%13.65M
2015-11-05BMO1.22120.46127.17122.47118.61122.5-3.70%-1.64%-5.28%8.46M
2015-07-23BMO1.2139.01138.26137.77136.5140.72-0.35%0.90%0.54%5.41M
2015-04-30BMO1.06108.06113.2109.5107.02110.94-3.27%▲-1.32%-4.54%12.90M
2015-01-29BMOCelgene Corp0.880.91120.87118.97119.58116.55121.090.51%1.08%1.60%4.90M
2014-10-23BMOCelgene Corp0.820.88100.494.7695.9895.6100.911.29%4.61%5.95%9.67M
2014-07-24BMOCelgene Corp0.770.886.1989.1287.2684.2587.76-2.09%-1.23%-3.29%8.68M
2014-04-24BMOCelgene Corp1.431.46141.25144.82142136.75142.49-1.95%▲-0.53%-2.47%8.82M
2014-01-30BMOCelgene Corp1.391.33153.98158.46160.15150.11160.831.07%-3.85%-2.83%13.67M
2013-10-24BMOCelgene Corp1.381.39157.96160158.89156.04160-0.69%-0.59%-1.27%7.67M
2013-07-25BMOCelgene Corp1.31.4140.65135.99139.02135.81140.792.23%1.17%3.43%6.11M
2013-04-25BMO1.35117.95118.278121116.25121.052.30%▲-2.52%-0.28%5.14M
2013-01-24BMO1.3197.4998.2298.2297.0498.77-0.74%-0.74%3.38M
2012-10-25BMO1.2774.3274.0674.6974.0675.50.85%-0.50%0.35%1.87M
2012-07-26BMOQ2 2012 Celgene Corp1.181.2267.4965.2867.4865.5368.83.37%0.01%3.39%5.20M
2012-04-26BMOQ1 2012 Celgene Corp1.131.0872.9277.9174.7472.3675.98-4.07%▲-2.44%-6.40%10.51M
2012-01-26BMOQ4 2011 Celgene Corp1.061.0572.6673.7973.9672.3474.630.23%-1.76%-1.53%3.99M
2011-10-27BMOQ3 2011 Celgene Corp0.951.0265.2966.4765.7164.4766.83-1.14%-0.64%-1.78%7.61M
2011-07-28BMOQ2 2011 Celgene Corp0.860.8959.9659.4861.1859.9262.322.86%-1.99%0.81%5.57M
2011-04-28BMOQ1 2011 Celgene Corp0.80.8358.845958.7257.2359.17-0.47%▲0.20%-0.27%4.80M
2011-01-27BMOQ4 2010 Celgene Corp0.7354.8556.1955.8654.5756.54-0.59%-1.81%-2.38%4.71M
2010-10-28BMOQ3 2010 Celgene Corp0.710.7561.259.461.560.9362.743.54%-0.49%3.03%7.82M
2010-07-29BMOQ2 2010 Celgene Corp0.660.6953.752.8554.6552.5654.893.41%-1.74%1.61%5.63M
2010-04-29BMOQ1 2010 Celgene Corp0.610.6361.6259.6363.4360.6463.476.37%▲-2.85%3.34%7.36M
2010-01-28BMOQ4 2009 Celgene Corp0.6256.858.1157.5256.5958-1.02%-1.25%-2.25%4.93M
2009-10-22BMOQ3 2009 Celgene Corp0.540.5655.9154.5856.465557.453.44%-0.97%2.44%8.01M
2009-07-23BMOQ2 2009 Celgene Corp0.4655.9747.1853.5853.556.1113.57%4.46%18.63%15.92M
2009-04-30BMOQ1 2009 Celgene Corp0.430.4442.7242.443.0841.543.761.60%▲-0.84%0.75%8.52M
2009-01-29BMOQ4 2008 Celgene Corp0.420.4352.1352.251.5951.4653.37-1.17%1.05%-0.13%3.85M
2008-10-23Q3 2008 Celgene Corp0.390.457.4758.0553.7753.6658.51-7.37%6.88%-1.00%6.46M
2008-07-24BMOQ2 2008 Celgene Corp0.350.3773.2670.4571.4870.2674.51.46%2.49%3.99%10.46M
2008-05-08Q1 2008 Celgene Corp0.340.3662.4962.4760.9960.3263-2.37%▲2.46%0.03%5.62M
2008-01-31BMOQ4 2007 Celgene Corp0.3156.1153.9653.6153.3856.32-0.65%4.66%3.98%6.40M
2007-10-25BMOQ3 2007 Celgene Corp0.280.2964.2270.1864.9360.2666.21-7.48%-1.09%-8.49%21.62M
2007-07-26BMOQ2 2007 Celgene Corp0.230.2660.258.756059.2560.972.13%0.33%2.47%9.90M
2007-05-03Q1 2007 Celgene Corp0.263.0361.6162.1862.1263.90.93%▲1.37%2.30%4.56M
2007-02-01Q4 2006 Celgene Corp0.1855.4156.155.6655.156.21-0.78%-0.45%-1.23%2.90M
2006-10-26Q3 2006 Celgene Corp0.140.1550.3349.6449.149.150.92-1.09%2.51%1.39%5.38M
2006-07-27BMOQ2 2006 Celgene Corp0.10.114648.9146.444.4747.68-5.13%-0.86%-5.95%7.97M
2006-04-27BMOQ1 2006 Celgene Corp0.070.0942.3937.740.0939.7842.596.34%▲5.74%12.44%11.21M
2006-01-26Q4 2005 Celgene Corp0.030.0270.7168.9168.9668.6570.980.07%2.54%2.61%4.42M
2005-11-03BMOQ3 2005 Celgene Corp0.060.0358.8557.6955.955.4960.63-3.10%5.28%2.01%7.28M
2005-07-28BMOQ2 2005 Celgene Corp0.070.0948.2447.2746.6446.548.6-1.33%3.43%2.05%4.82M
2005-04-28BMOQ1 2005 Celgene Corp0.050.0638.1739.6139.6238.1139.620.03%▲-3.66%-3.64%5.10M
2005-01-27BMOQ4 2004 Celgene Corp28.2728.7829.1527.629.421.29%-3.02%-1.77%4.40M
2004-10-21BMOQ3 2004 Celgene Corp58.2262.3861.0557.8761.18-2.13%-4.64%-6.67%15.59M
2004-07-22BMOQ2 2004 Celgene Corp5148.7448.1146.6551.88-1.29%6.01%4.64%14.67M
2004-04-22BMOQ1 2004 Celgene Corp56.0954.353.9153.256.16-0.72%▲4.04%3.30%7.20M
2004-01-29BMOQ4 2003 Celgene Corp41.0441.4741.7440.2341.750.65%-1.68%-1.04%12.19M
2003-10-23BMOQ3 2003 Celgene Corp41.0440.1641.339.6542.482.84%-0.63%2.19%12.10M
2003-07-24BMOQ2 2003 Celgene Corp33.2534.0436.7633.0836.797.99%-9.55%-2.32%10.79M
2003-04-24BMOQ1 2003 Celgene Corp28.2626.7927.6427.3429.083.17%▲2.24%5.49%10.01M
2003-01-30BMOQ4 2002 Celgene Earn22.4821.8721.221.1423.1-3.06%6.04%2.79%9.64M
2002-10-24BMOQ3 2002 Celgene Earn19.162020.0118.6320.090.05%-4.25%-4.20%8.50M
2002-07-25BMOQ2 2002 Celgene Earn14.7514.7514.7814.315.740.20%-0.20%7.23M
2002-04-25BMOQ1 2002 Celgene Earn19.8121.1221.0619.121.13-0.28%▲-5.94%-6.20%6.19M
2002-01-30BMOQ4 2001 Celgene Earn27.1425.8324.322.6527.44-5.92%11.69%5.07%18.81M
2001-10-25BMOQ3 2001 Celgene Earn32.1229.1628.7528.7332.97-1.41%11.72%10.15%11.50M
2001-07-26BMOQ2 2001 Celgene Earn27.225.0524.5424.5428.19-2.04%10.84%8.58%9.21M
2001-04-26BMOQ1 2001 Celgene Earn15.2116.9117.714.418.824.67%▲-14.07%-10.05%51.65M
2001-02-01BMOQ4 2000 Celgene Earn27.7527.7528.5927.529.383.03%-2.94%7.23M
2000-10-26BMOQ3 2000 Celgene Earn64.8164.886462.2570.12-1.36%1.27%-0.11%5.27M
2000-07-27BMOQ2 2000 Celgene Earn50.9446.7548.9445.6251.694.68%4.09%8.96%5.92M
2000-04-27BMOCelgene Earnings Rel46.8841.3837.753647.38-8.77%▲24.19%13.29%6.26M
2000-01-27BMOCelgene Earnings Rel75.580.579.6371.7580-1.08%-5.19%-6.21%1.20M
1999-11-10Celgene Earnings Rel4241.8742.0641.6242.380.45%-0.14%0.31%1.35M
1999-08-11Celgene Earnings Rel15.5614.6214.8814.515.631.78%4.57%6.43%1.21M

Login | Register
Tuesday May 23, 2017   EST
Enter a Ticker:

Economic Calendar

Redbook 8:55 AM ET PMI Composite Flash 9:45 AM ET New Home Sales 10:00 AM ET Richmond Fed Manufacturing Index 10:00 AM ET 4-Week Bill Auction 11:30 AM ET 52-Week Bill Auction 11:30 AM ET 2-Yr Note Auction 1:00 PM ET Neel Kashkari Speaks 3:15 PM ET Patrick Harker Speaks 5:00 PM ET  

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY239.950.430.18%23,950,384

Upgrades/Downgrades